# Gender Dysphoria in Children and Adolescents: Assessment and Care

## Introduction

Gender dysphoria refers to the distress that may accompany the incongruence between an individual's experienced gender and their sex assigned at birth. Child and adolescent psychiatrists are increasingly called upon to evaluate and support gender-diverse youth. Clinical care in this area requires a thorough understanding of developmental trajectories, a respectful and affirming assessment approach, and familiarity with the evolving evidence base regarding psychosocial and medical interventions.

## Key Terminology

Gender identity is a person's internal sense of their gender, whether male, female, nonbinary, or another identity. Gender expression is the external manifestation of gender through clothing, behavior, and appearance. Cisgender describes individuals whose gender identity aligns with their sex assigned at birth. Transgender describes those whose gender identity differs from their sex assigned at birth. Nonbinary refers to gender identities outside the traditional male/female binary. Gender dysphoria is the clinically significant distress associated with gender incongruence. It is important to recognize that gender diversity is not inherently pathological; dysphoria arises from the distress, not the identity itself.

## Epidemiology

Surveys suggest that 1-3% of adolescents identify as transgender or gender diverse. Referrals to gender clinics have increased substantially over the past decade. There is increasing visibility of assigned-female-at-birth adolescents presenting for gender care. Gender-diverse youth have significantly higher rates of depression, anxiety, self-harm, and suicidality compared to cisgender peers.

## Developmental Trajectories

### Prepubertal Children

Gender-diverse behavior is common in young children and is often normative. Historical studies suggested that the majority of prepubertal children with gender dysphoria do not persist into adolescence, a pattern termed desistance, though these studies have significant methodological limitations. Persistence is more likely in children with intense, consistent, and insistent cross-gender identification. Social transition in prepubertal children remains an area of active clinical debate.

### Adolescents

Gender dysphoria emerging or intensifying at puberty is a common presentation. Persistence rates are significantly higher in adolescents than in prepubertal children. Assessment should explore the relationship between puberty-related body changes and distress. It is important to distinguish gender dysphoria from body dysmorphia, trauma-related identity disturbance, and other conditions that may mimic or complicate the presentation.

## Assessment Framework

### Comprehensive Evaluation

A thorough evaluation includes a detailed history of gender identity development from early childhood, assessment of current gender dysphoria with identification of specific sources of distress, a comprehensive psychiatric evaluation for comorbid conditions including depression, anxiety, ASD, ADHD, PTSD, and eating disorders, assessment of family dynamics, acceptance, and support, evaluation of social functioning, peer relationships, and the school environment, developmental history including neurodevelopmental screening, and trauma history with safety assessment for suicidality and self-harm.

### Differential Considerations

Gender dysphoria should be distinguished from body dysmorphic disorder. The influence of trauma, dissociation, or identity confusion should be assessed. The role of autism spectrum disorder warrants consideration, as ASD is overrepresented in gender-diverse youth; this co-occurrence does not invalidate gender identity but does warrant careful assessment. It is important to evaluate whether distress is primarily from gender incongruence or from minority stress related to rejection, discrimination, and bullying.

## Psychosocial Interventions

Supportive psychotherapy allows exploration of gender identity in an open, non-directive manner. Family therapy addresses parental reactions, facilitates acceptance, and supports the child. School consultation regarding name, pronouns, bathroom access, and anti-bullying measures creates a more supportive educational environment. Connection to peer support groups and community resources reduces isolation. Comorbid psychiatric conditions should be addressed with evidence-based treatments.

## Medical Interventions

### Summary of Medical Interventions

| Intervention | Typical Timing | Reversibility | Key Monitoring | Purpose |
|-------------|---------------|---------------|----------------|---------|
| Puberty suppression (GnRH agonists) | Tanner stage 2+ | Reversible upon discontinuation | Bone density, growth, psychological status | Provide time; reduce distress from unwanted pubertal changes |
| Gender-affirming hormones (E2 or T) | Age 16+ (case-by-case earlier) | Partially irreversible | Hormonal levels, metabolic parameters, fertility | Produce desired secondary sex characteristics |
| Surgical interventions | Age 18+ (top surgery case-by-case in minors) | Irreversible | Comprehensive evaluation required | Align physical body with gender identity |

### Puberty Suppression

GnRH agonists such as leuprolide suppress pubertal development. They are considered at Tanner stage 2 or later. The effects are reversible upon discontinuation. The purpose is to provide time for continued psychological assessment and to reduce distress from unwanted pubertal changes. Monitoring should include bone density, growth, and psychological status.

### Gender-Affirming Hormone Therapy

Estrogen for transfeminine individuals or testosterone for transmasculine individuals is typically initiated at age 16, though some guidelines support earlier initiation on a case-by-case basis. These hormones produce partially irreversible physical changes including voice deepening, breast development, and facial hair growth. Informed consent must include thorough discussion of risks, benefits, fertility implications, and unknowns.

### Surgical Interventions

Surgical interventions are generally deferred until the age of majority at 18 years in most guidelines. Top surgery, or chest masculinization, may be considered for transmasculine adolescents on a case-by-case basis. Comprehensive evaluation and multidisciplinary team involvement are required.

## Ethical and Legal Considerations

Informed consent and assent must be developmentally appropriate and thorough. Parental disagreement about treatment can create complex ethical dilemmas. Legislative restrictions on gender-affirming care for minors vary by jurisdiction and are rapidly evolving. Clinicians must balance respect for adolescent autonomy with parental rights and the precautionary principle. Conversion therapy, which attempts to change gender identity, is opposed by all major medical organizations.

## Clinical Pearls

Gender diversity is not a disorder; clinical attention is warranted when there is distress or functional impairment. Comprehensive psychiatric assessment is essential because comorbid conditions are common and must be addressed alongside, not instead of, gender-related concerns. Family acceptance is the single strongest protective factor against depression, suicidality, and substance use in gender-diverse youth. The evidence base is evolving, and clinicians must stay current with guidelines while practicing individualized, patient-centered care.

## References

1. Hembree WC, et al. "Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline." *Journal of Clinical Endocrinology and Metabolism*. 2017;102(11):3869-3903.
2. de Vries ALC, Cohen-Kettenis PT. "Clinical Management of Gender Dysphoria in Children and Adolescents." *Journal of Homosexuality*. 2012;59(3):301-320.
3. Rafferty J, AAP Committee on Psychosocial Aspects of Child and Family Health. "Ensuring Comprehensive Care and Support for Transgender and Gender-Diverse Children and Adolescents." *Pediatrics*. 2018;142(4):e20182162.
4. World Professional Association for Transgender Health. *Standards of Care for the Health of Transgender and Gender Diverse People*, 8th ed. 2022.